Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Haas

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
International Orthopaedics|May 22, 2013
Improvement of research quality in the fields of orthopaedics and trauma: a global perspectiveHangama C Fayaz, Norbert Haas, James Kellam, et al.
Critical Care Medicine|October 16, 2004
The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trialAndreas Seekamp, Martijn van Griensven, Erwin Dhondt, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
International Orthopaedics|May 22, 2013
Improvement of research quality in the fields of orthopaedics and trauma: a global perspectiveHangama C Fayaz, Norbert Haas, James Kellam, et al.
Critical Care Medicine|October 16, 2004
The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trialAndreas Seekamp, Martijn van Griensven, Erwin Dhondt, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 4